ZBIO (STOCKS)
Zenas BioPharma, Inc. Common Stock
$19.850000
+0.050000 (+0.25%)
Prev close: $19.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Leon Oliver Moulder
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,181.23M
- Employees
- 130
- P/E (TTM)
- -2.18
- P/B (TTM)
- 3.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.46 | $-1.62 | +0.1577 | +9.75% |
|
Dec 2025 (Q4)
|
$-4.54 | $-1.05 | -3.4914 | -332.96% |
|
Sep 2025 (Q3)
|
$-1.22 | $-1.07 | -0.1514 | -14.17% |
|
Jun 2025 (Q2)
|
$-1.25 | $-1.07 | -0.1790 | -16.71% |
Financial Statements
| Assets | $747.68M |
| Current Assets | $730.16M |
| Cash | $718.50M |
| Other Current Assets | $11.66M |
| Noncurrent Assets | $17.52M |
| Fixed Assets | $28.00K |
| Non-current Prepaid Expenses | $14.54M |
| Other Non-current Assets | $2.96M |
| Liabilities | $411.85M |
| Current Liabilities | $61.16M |
| Accounts Payable | $8.94M |
| Wages | $5.62M |
| Other Current Liabilities | $46.60M |
| Noncurrent Liabilities | $350.69M |
| Equity | $335.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $335.83M |
| Liabilities And Equity | $747.68M |